Sprycel dasatinib: Phase II data

Bristol-Myers Squibb Co. (BMY), New York, N.Y. Product: Sprycel dasatinib ( BMS-354825) Business: Cancer Molecular target: Bcr-Abl tyrosine kinase; Src Description: Small molecule inhibitor of Bcr-...